Details for Patent: 4,012,444

Summary for Patent: 4,012,444

Title:	5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
Abstract:	Compounds of the formula: ##STR1## and physiologically acceptable acid addition salts thereof, in which R.sup.1 is A. an arylalkyl group, the alkyl portion of which contains from 1 to 6 carbon atoms and the aryl portion of which may be substituted by one or more alkoxy groups or hydroxy groups; or B. an aryloxyalkyl group, the alkyl portion of which contains from 1 to 6 carbon atoms, and the aryloxy portion of which is substituted with one or more alkoxy or hydroxy groups. These compounds have a blocking action on both .alpha.- and .beta.-adrenergic receptors. Processes for the production of these compounds and pharmaceutical compositions containing them are also provided.
Inventor(s):	Lunts; Lawrence Henry Charles (London, EN), Collin; David Trevor (London, EN)
Assignee:	Allen & Hanburys Limited (London, EN)
Application Number:	05/420,547
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 4,012,444

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,012,444

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	34379/69	Jul 8, 1969

International Family Members for US Patent 4,012,444

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	280996
Austria	300763
Belgium	704037
Belgium	752892